News
And increasing distribution of its "Platinum" benchtop protein sequencing device holds promise. However, at this juncture, and for most retail investors, Olink acquirer Thermo Fisher is a better ...
Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel with results reported in absolute ...
Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time. Requiring just 4 µL of sample, it enables ...
Thermo Fisher Scientific plans to acquire Olink for $3.1 billion. The deal would add Olink's proteomics technology to Thermo Fisher's life sciences solutions. Thermo Fisher's offer price of $26 ...
Oct 17 (Reuters) - Thermo Fisher Scientific (TMO.N), opens new tab would acquire Olink Holding AB (OLK.O), opens new tab in a deal valued at $3.1 billion, the companies said on Tuesday ...
Thermo Fisher is paying a high price for Olink, but its size relative to the overall company is not big enough to significantly affect Thermo's valuation. With little upside from current prices to ...
Join us at the Olink Proteomics Conference, a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing, ...
Hosted on MSN11mon
Olink gains after receiving German approval for sale to Thermo FisherOlink (NASDAQ:OLK) rose 2.8% after receiving German antitrust approval for its planned sale to Thermo Fisher (NYSE:TMO). The German Federal Cartel Office approved the transaction on Monday ...
Shares of Olink Holding AB (NASDAQ: OLK) are skyrocketing 66.1% higher as of 11 a.m. ET on Tuesday. The huge jump came after Thermo Fisher Scientific (NYSE: TMO) announced plans to acquire Olink ...
Thermo Fisher Scientific Inc. will acquire Olink Holding AB in a deal that values the pharmaceutical products and services company at about $3.1 billion. Both boards approved Thermo Fisher’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results